{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:04:10Z","timestamp":1770822250363,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.cancergencyto.2005.01.006","type":"journal-article","created":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T12:31:28Z","timestamp":1112099488000},"page":"99-109","source":"Crossref","is-referenced-by-count":27,"title":["Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype\/genotype fluorescence in situ hybridization"],"prefix":"10.1016","volume":"158","author":[{"given":"Marilyn L.","family":"Slovak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Pagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Somlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2005.01.006_bib1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808","article-title":"The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies","volume":"96","author":"Willis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib3","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib4","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib5","first-page":"3854","article-title":"Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization","volume":"55","author":"Drach","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.1996.d01-2939.x","article-title":"Multiple myeloma: almost all patients are cytogenetically abnormal","volume":"94","author":"Zandecki","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib7","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V90.2.526","article-title":"The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization","volume":"90","author":"Nishida","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib8","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood-2003-02-0493","article-title":"The recurrent IGH translocations are highly associated with nonhyperdiploid variant multiple myeloma","volume":"102","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood.V97.6.1566","article-title":"Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy","volume":"97","author":"Facon","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib10","first-page":"715","article-title":"Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an Eastern Cooperative Oncology Group study","volume":"62","author":"Fonseca","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.2000.18.4.804","article-title":"Predictive role of interphase cytogenetics for survival of patients with multiple myeloma","volume":"18","author":"Konigsberg","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib12","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","article-title":"Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization","volume":"95","author":"Zojer","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1182\/blood.V93.1.55","article-title":"Total therapy with tandem transplants for newly diagnosed multiple myeloma","volume":"93","author":"Barlogie","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy","volume":"92","author":"Drach","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib15","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome","volume":"94","author":"Avet-Loiseau","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib16","first-page":"529","article-title":"Gene abnormalities in multiple myeloma: the relevance of TP53, MDM2, and CDKN2A","volume":"88","author":"Elnenaei","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib17","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","article-title":"Hypodiploidy is a major prognostic factor in multiple myeloma","volume":"98","author":"Smadja","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/gcc.10275","article-title":"Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases","volume":"38","author":"Smadja","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1182\/blood.V82.3.884.884","article-title":"In situ hybridization on May-Grunwald Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities","volume":"82","author":"van Lom","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1365-2141.1996.d01-1945.x","article-title":"Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia","volume":"95","author":"Bernell","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s002770100366","article-title":"New insights into the biology of multiple myeloma using a combination of May-Gr\u00fcnwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level","volume":"80","author":"Nickenig","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.exphem.2003.12.001","article-title":"Determination of chromosome 13 status in bone marrow cells of patients with multiple myeloma using combined morphologic and fluorescence in situ hybridization analysis","volume":"32","author":"Hardan","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib23","article-title":"An international system for human cytogenetic nomenclature","author":"ISCN","year":"1995"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/sj.leu.2402581","article-title":"Chimerism testing and detection of minimal residual disease after allogeneic hematopoietic transplantation using the BioView (Duet) combined morphological and cytogenetical analysis","volume":"16","author":"Shimoni","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2402797","article-title":"Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma","volume":"17","author":"Debes-Marun","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1701626","article-title":"Interphase FISH: a rapid method for detecting malignant plasma cells in multiple myeloma patients submitted to autologous transplantation","volume":"23","author":"Dascalescu","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib27","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1158\/1078-0432.CCR-04-0467","article-title":"A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma","volume":"10","author":"Dring","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib28","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1997.15.7.2659","article-title":"Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants","volume":"15","author":"Tricot","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2141.2002.03757.x","article-title":"Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma","volume":"118","author":"Fassas","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib30","doi-asserted-by":"crossref","unstructured":"Zhu L, Somlo G, Zhou Bn, Shao J, Bedell V, Slovak ML, Liu X, Luo J, Yen Y. Fibroblast growth factor receptor 3 inhibited by short-hairpin RNAs leads to apoptosis in multiple myeloma. Mol Cancer Ther 2005. In press.","DOI":"10.1158\/1535-7163.MCT-04-0330"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood.V95.3.992.003k29_992_998","article-title":"Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis","volume":"95","author":"Plowright","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood.V97.3.729","article-title":"Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma","volume":"97","author":"Chesi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib33","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1182\/blood-2002-09-2968","article-title":"Translocation of the IGH locus is nearly ubiquitous in multiple myeloma as detected by immuno-FISH","volume":"101","author":"Boersma-Vreugdenhil","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib34","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1046\/j.1365-2141.2002.03529.x","article-title":"Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance","volume":"117","author":"Zojer","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib35","first-page":"300","article-title":"Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells","volume":"49","author":"Fiserova","year":"2002","journal-title":"Neoplasma"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib36","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/gcc.20078","article-title":"MDS\/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q)","volume":"41","author":"Nilsson","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2005.01.006_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bmt.1700670","article-title":"Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation","volume":"19","author":"Gertz","year":"1997","journal-title":"Bone Marrow Transplant"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805000440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460805000440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:19:11Z","timestamp":1586186351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460805000440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0165460805000440"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.01.006","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}